Industry News

Northwest Biotherapeutics, a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, today announced that Nasdaq has accepted NW Bio's proposed remediation plan to resolve Nasdaq's finding, previously disclosed by the Company, that NW Bio failed to comply with certain Nasdaq listing rules with regard to certain securities issuances to Cognate BioServices, Inc.. As a result of this acceptance,..."/>
NASDAQ Accepts NW Bio Remediation Plan For Shares and Warrants Previously Issued to Cognate BioServices
Titan Medical Inc., a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery, today announced that Dr. Rafael Sanchez-Salas of the Institute Mutualiste Montsouris will present an overview of the SPORT™ Surgical System as part of his presentation in the Technology Forum at the 13 th Meeting of the European Association of Urology Robotic Urology Section."/>
Titan Medical's Sport(TM) Surgical System to Be Featured in Presentation by Leading Urological Surgeon at the 13th Annual Meeting of the EAU Robotic Section in Milan, Italy
ResMed welcomed positive results from a multicenter, randomized controlled trial known as HOT-HMV. The study was presented today during the 2016 European Respiratory Society International Congress, in London. The HOT-HMV trial studied COPD patients who were hypercapnic, that is, had high carbon dioxide levels in their blood, and who were hospitalized after their COPD worsened."/>
New Study Shows Using Non-Invasive Ventilation Therapy to Treat Patients with Chronic Obstructive Pulmonary Disorder (COPD) at Home Significantly Reduces Risk of Re-Hospitalization and Death
Agenus Inc., an immuno-oncology company developing antibodies, including checkpoint inhibitors and other checkpoint modulators, and cancer vaccines, today announced that the Company will present at the Rodman& Renshaw 18th Annual Global Investment Conference on Monday, September 12 th at 2:10 p.m. Eastern Time. The conference will take place at the Lotte New York Palace Hotel in New York City. The live and archived webcast of the..."/>
Agenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Peregrine Pharmaceuticals, Inc., a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing its proprietary R&D pipeline, today announced that the National Comprehensive Cancer Network ® Oncology Research Program has awarded three grants to investigators to support research of bavituximab in combination with other therapeutics..."/>
National Comprehensive Cancer Network (NCCN) Awards Three Grants for Combination Studies of Peregrine Pharmaceuticals’ Bavituximab in Multiple Cancers
Laboratory Corporation of America ® Holdings today announced it will participate at the Morgan Stanley Global Healthcare Conference. LabCorp’ s presentation is planned for Monday, September 12, 2016 at 10:30 AM. A live audio webcast will be available via the Company website at www.labcorp.com and archived for replay."/>
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
Infinity Pharmaceuticals, Inc. today announced that new preclinical data as well as early clinical data from an ongoing Phase 1 study will be presented for IPI-549, an immuno-oncology development candidate that selectively inhibits PI3K-gamma, during the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival taking place September 25-28, 2016, in New York City."/>
Infinity Announces Presentations On IPI-549 At Upcoming Immuno-Oncology Meeting
TeamHealth Holdings, Inc., a leading physician services organization, today announced the appointment of Leif Murphy as its new President and Chief Executive Officer. Murphy will succeed Michael D. Snow, who is retiring. "We welcome Leif to TeamHealth as we enhance our service offerings to hospital and post-acute partners, recruit and retain the best and brightest clinicians and play a leadership role in the evolving healthcare..."/>
TeamHealth Announces Leadership Transition
AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2016 Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016, at 2:55 p.m. EST. The conference will be held at the Grand Hyatt in New York City.."/>
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
Versartis, Inc., an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone for growth hormone deficiency, today announced that Jay Shepard, President and CEO, is scheduled to present at the Morgan Stanley Global Healthcare Conference on September 13, 2016 at the Grand Hyatt Hotel in New York City.. Event: Morgan Stanley Global Healthcare Conference 2016 Date:..."/>
Versartis to Present at the Morgan Stanley Global Healthcare Conference
LifePoint Health, Inc. today announced the appointment of Michael S. Coggin as Chief Financial Officer, effective September 30, 2016. Coggin, who has served as Chief Accounting Officer of the Company since 2008, succeeds Leif Murphy, currently Chief Financial Officer, who is leaving the Company to pursue another opportunity."/>
LifePoint Health Appoints Michael S. Coggin as Chief Financial Officer
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac surgery, announced today the appointment of James McDermid to the position of Chief Human Resources Officer, effective immediately. McDermid joins the company from Medtronic where he was Group Vice President, Human Resources for the Cardiac and Vascular Group. He will report to Pat Mackin, Chairman, President, and Chief Executive Officer."/>
CryoLife Appoints James McDermid as Chief Human Resources Officer
Aetna and Piedmont Healthcare announced today that the two organizations have signed a new contract. The agreement will give Aetna members continued in-network access to all Piedmont facilities and more than 1,400 Piedmont Clinic physicians through February 28, 2019.. “Our new contract is a testament to the strong, longstanding relationship we have with Piedmont Healthcare,” said Angela Meoli, Aetna market president, Georgia.“ We have worked together for many years in..."/>
Aetna and Piedmont Healthcare Announce New Contract
Stellar Biotechnologies, Inc., the leader in sustainable manufacture of Keyhole Limpet Hemocyanin, today announced that the Company will present at the Rodman& Renshaw 18th Annual Global Investment conference being held September 11-13, 2016 at the Lotte New York Palace Hotel in New York, NY. Stellar Biotechnologies Presentation Details: Conference: Rodman& Renshaw 18th Annual Global Investment Conference Date: Tuesday, September 13, 2016 Time:..."/>
Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference
Aeolus Pharmaceuticals, Inc., a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage and infection announced the release of data confirming the efficacy of AEOL 10150 as a medical countermeasure against sulfur mustard gas inhalation."/>
Aeolus Announces Positive Data Confirming Efficacy of AEOL 10150 as a Medical Countermeasure Against Sulfur Mustard Gas
CEL-SCI Corporation today announced that its founder, President and Chairman of the Board, Maximilian de Clara has resigned for personal health reasons, effective immediately. The 87 year-old visionary funded the original research of what has become CEL-SCI’ s investigational drug Multikine* at the Max Planck Institute in Germany. From this he started the Company and now the Multikine Phase 3 study is being run in 24 countries with multiple respected partners."/>
CEL-SCI Announces Resignation of its Founder for Health Reasons
EDAP TMS SA, the global leader in therapeutic ultrasound, today announced that Marc Oczachowski, Chief Executive Officer of EDAP TMS, is scheduled to present at the 18 th Annual Rodman& Renshaw Global Investment Conference being held September 11-13, 2016 at the Lotte New York Palace Hotel in New York, NY.. Details of the presentations are as follows:. Investors attending the conference who would like to schedule a one-on-one meeting with EDAP’ s management..."/>
EDAP TMS to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
Integer Holdings Corp today announced that Michael Dinkins, executive vice president and chief financial officer, will participate in a fireside chat at the 2016 Morgan Stanley Global Healthcare Conference on Monday, September 12, at approximately 4:50 p.m. at the Grand Hyatt Hotel in New York.. A live webcast of this event will be available on Integer’ s investor relations website at http://investor.greatbatch.com. The webcast replay will be..."/>
Integer Announces Participation in the 2016 Morgan Stanley Global Healthcare Conference
Cellectar Biosciences, Inc., an oncology-focused biotechnology company, today announces that Jim Caruso, CEO of Cellectar, will present at the 18 th Annual Rodman& Renshaw Global Investment Conference being held at the Lotte New York Palace Hotel from September 11-13, 2016.. The company’ s presentation will be held in the Kennedy I room on the fourth floor on Monday, September 12, 2016 at 12:30 PM ET and will be webcast via..."/>
Cellectar Biosciences To Present at the 18th Annual Rodman & Renshaw Global Investment Conference
TapImmune, Inc., a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer& metastatic disease, today issued a shareholder update regarding significant recent financial, clinical and regulatory milestones achieved, as well as an outlook on future catalysts. We believe recent events have been..."/>
TapImmune Issues Update: Multiple Phase 2 Trials, over $9 Million in New Funding & NASDAQ Uplisting Application
Versartis, Inc., an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone for growth hormone deficiency, today announced that it will host an Investor Symposium in New York City on September 15, 2016. The event will bring together leading experts in the GHD space to share their knowledge and treatment experience. Topics to be discussed include GHD treatment..."/>
Versartis to Host Investor Symposium Featuring Leading Experts in Growth Hormone Deficiency
Thermo Fisher Scientific Inc., the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016, at 8:10 a.m. at the Grand Hyatt New York, New York. You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com. Thermo Fisher Scientific Inc. is the world leader in serving..."/>
Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 14, 2016
OPKO Health, Inc. will present abstracts at the 55 th Annual Meeting of the European Society for Paediatric Endocrinology to be held in Paris, France on September 10-12, 2016.. Twenty four month phase 2 efficacy, safety, pharmacokinetic, and pharmacodynamic data from OPKO’ s long acting human growth hormone, hGH-CTP, in growth hormone deficient children will be presented. OPKO will also hold a workshop for participating endocrinologists to review final phase 3 study plans."/>
OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology547 Articles
Consumer Discretionary518 Articles
Financials331 Articles
Health Care319 Articles
Industrials316 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.